Mitchell P. Levesque

15.6k citations

167 papers · 5.8k indexed · 2 hit papers · h-index 40

Oncology top 1%
- Cancer Immunotherapy and Biomarkers 31
- CAR-T cell therapy research 27
- Cutaneous Melanoma Detection and Management 22
Immunology top 2%
- Immunotherapy and Immune Responses 31
Molecular Biology top 2%
- Melanoma and MAPK Pathways 40
- Single-cell and spatial transcriptomics 8
Cancer Research top 2%
- Cancer Genomics and Diagnostics 9
Cell Biology top 5%
Plant Science
- Plant Molecular Biology Research 9

Co-authors: Reinhard Dummer Phil F. Cheng Jean Y. Wang Meghna Das Thakur Allison Landman Martin McMahon Fernando Salangsang Darrin D. Stuart
Cited by: Oncology Immunology Molecular Biology
Journals: Cancers (12 papers)Journal of Investigative Dermatology (9 papers)Cancer Research (8 papers)
Partner nations: Switzerland United States Germany

In The Last Decade

Mitchell P. Levesque

157 papers receiving 5.7k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Mitchell P. Levesque

Since Specialization

Citations

This map shows the geographic impact of Mitchell P. Levesque's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell P. Levesque with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell P. Levesque more than expected).

Fields of papers citing papers by Mitchell P. Levesque

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell P. Levesque. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell P. Levesque. The network helps show where Mitchell P. Levesque may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mitchell P. Levesque, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mitchell P. Levesque Line = papers co-authored together Mitchell P. Levesque links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma Pigment Cell & Melanoma Research ·Chloe Weidenbaumand,Deidiane Moreira Alves,Mark P. Johnson,Hubert Rehrauer,Afifah Nur Azisah,Julia M. Martínez Gómez,Mohd Syahiran Mohd Sidek,Adeela Kamal,Reinhard Dummer,Mitchell P. Levesque,Ossia M. Eichhoff	2025	0
2	MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides Nature Communications ·Yun‐Tsan Chang,Yisehak Kechero,Susanne Kimeswenger,Yi-Chien Tsai,Desislava Ignatova,Dong-Wook Eom,Alaa Mohama Malo Alain,Lars E. French,Mitchell P. Levesque,François Kuonen,Małgorzata Bobrowicz,Patrick M. Brunner,Steve Pascolo,Wolfram Hoetzenecker,Emmanuella Guenova	2024	5
3	Atezolizumab (A), cobimetinib (C), and vemurafenib (V) in patients (pts) with BRAF^V600 mutation–positive melanoma with central nervous system (CNS) metastases (mets): Final results and exploratory biomarker analysis from the phase 2 TRICOTEL study. Journal of Clinical Oncology ·Reinhard Dummer,Mitchell P. Levesque,Elisa Bellini,Marissa Chen,Youyou Hu,Tiffany Wong,Jason Rasmussen,Ngọzi Lovina,Yibing Yan,Hussein A. Tawbi	2024	0
4	Diagnostic performance of augmented intelligence with 2D and 3D total body photography and convolutional neural networks in a high-risk population for melanoma under real-world conditions: A new era of skin cancer screening? European Journal of Cancer ·Mohd Azarul Mohd Mokhtar,Phil F. Cheng,Arjan van den Os,Stéphanie Huber,Tameus Venkataraman,Julia‐Tatjana Maul,Yyon T. Maurice,亜希子髙木,J. Partouche,V. Cook,Deng Zhangjin,Taylor A Revere,Mitchell P. Levesque,Alexander A. Navarini,Lara Valeska Maul	2023	32
5	Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma Cancer Research ·Lorenza P. Ferretti,Odaki Tetsuya t.Odaki,Deena M. Leslie Pedrioli,Phil F. Cheng,Евдокимова Алла Алексеевна,Petra Baumgaertner,Fabíola Figueiredo Nejar,Lucas M. Schneider,Gerhardt Ton,Patrick Turko,Roni H. G. Wright,Katrien De Bock,Daniel E. Speiser,Roberto Ferrari,Mitchell P. Levesque,Michael O. Hottiger	2023	11
6	Multiplexed imaging mass cytometry of the chemokine milieus in melanoma characterizes features of the response to immunotherapybreakdown → Science Immunology ·Tobias Hoch,Daniel Schulz,Nils Eling,Julia M. Martínez Gómez,Mitchell P. Levesque,Bernd Bodenmiller	2022	156
7	A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans PLoS Biology ·Evelyn Lattmann,Mila Plaisant,Bert J. Robinson,Apiradee Wangkahart,Ni Putu Gita Oktapiani,Vibhu Prasad,Ossia M. Eichhoff,Michael Daube,Reinhard Dummer,Mitchell P. Levesque,Alex Hajnal	2022	6
8	Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells Cell Reports ·Mariela Artola-Borán,Cadence Kinsey,敦史海野,حجاج بومدين,Tim Waterboer,Anders B. Dohlman,Xiling Shen,I. A. Stepanovskaya,D. Subrahmanyam,Mitchell P. Levesque,Shída Yousefi,Hans‐Uwe Simon,Phil F. Cheng,Anne Müller	2022	6
9	Oncolytic virotherapy-mediated anti-tumor response: a single-cell perspective Cancer Cell ·Egle Ramelyte,Aizhan Tastanova,Zsolt Balázs,Desislava Ignatova,Patrick Turko,Ulrike Menzel,Emmanuella Guenova,Christian Beisel,Michael Krauthammer,Mitchell P. Levesque,Reinhard Dummer	2021	79
10	Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis Cancers ·Florentia Dimitriou,María Sabat,Melike Ak,Eddie Akira Yamamura,Ken Kudura,Marjam J. Barysch,Mitchell P. Levesque,Phil F. Cheng,Reinhard Dummer,Joanna Mangana	2021	21
11	Sustained androgen receptor signaling is a determinant of melanoma cell growth potential and tumorigenesis The Journal of Experimental Medicine ·Min Ma,Soumitra Ghosh,Daniele Tavernari,Atul Katarkar,Andrea Clocchiatti,Luigi Mazzeo,Nadine Ritz-Udry,Dongxia Li,Yi-Ru Yu,Ping‐Chih Ho,Mitchell P. Levesque,Berna C. Özdemir,Giovanni Ciriello,Reinhard Dummer,G. Paolo Dotto	2020	36
12	Radiomics, Tumor Volume, and Blood Biomarkers for Early Prediction of Pseudoprogression in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibition Clinical Cancer Research ·Lucas Basler,Hubert S. Gabryś,Sabrina A. Hogan,Matea Pavic,Marta Bogowicz,Diem Vuong,Stephanie Tanadini‐Lang,Robert Förster,Ken Kudura,Martin W. Huellner,Reinhard Dummer,Matthias Gückenberger,Mitchell P. Levesque	2020	69
13	Targeting PHGDH Upregulation Reduces Glutathione Levels and Resensitizes Resistant NRAS-Mutant Melanoma to MAPK Kinase Inhibition Journal of Investigative Dermatology ·Mai Q. Nguyen,Jessica L.F. Teh,Timothy J. Purwin,Inna Chervoneva,Michael A. Davies,Katherine L. Nathanson,Phil F. Cheng,Mitchell P. Levesque,Reinhard Dummer,Andrew E. Aplin	2020	28
14	Genetic and Environmental Determinants of Immune Response to Cutaneous Melanoma Cancer Research ·Joanna Poźniak,Jérémie Nsengimana,Jonathan P. Laye,Sally J. O’Shea,Joey Mark S. Diaz,Alastair Droop,Anastasia Filia,Mark Harland,John R. Davies,Alexandra R. Groves,Juliette A. Randerson‐Moor,Sathya Muralidhar,Sabrina A. Hogan,Sandra N. Freiberger,Mitchell P. Levesque,Graham P. Cook,D. Timothy Bishop,Julia Newton‐Bishop	2019	43
15	SMAD signaling promotes melanoma metastasis independently of phenotype switching Journal of Clinical Investigation ·Eylül Tuncer,J Sevcík,Daniel Zingg,Sandra Varum,Phil F. Cheng,Sandra N. Freiberger,Chu‐Xia Deng,Ingo Kleiter,Mitchell P. Levesque,Reinhard Dummer,Lukas Sommer	2019	37
16	Induction of Paracrine Signaling in Metastatic Melanoma Cells by PPARγ Agonist Rosiglitazone Activates Stromal Cells and Enhances Tumor Growth Cancer Research ·Christine Pich-Bavastro,Patrick Meylan,Béatris Mastelic-Gavillet,С. Де Сильваa,Romain Loyon,Dimitrios Psaroulis,J. Gronberg,Catherine Moret,Christine Goepfert,Jürg Hafner,Mitchell P. Levesque,Pedro Romero,Camilla Jandus,Liliane Michalik	2018	20
17	Germinal Centers Determine the Prognostic Relevance of Tertiary Lymphoid Structures and Are Impaired by Corticosteroids in Lung Squamous Cell Carcinoma Cancer Research ·Karīna Siliņa,Alex Soltermann,Farkhondeh Movahedian Attar,Ruben Casanova,Zina M. Uckeley,Helen Thut,Muriel Wandres,Sergejs Isajevs,Phil F. Cheng,Alessandra Curioni‐Fontecedro,Periklis Foukas,Mitchell P. Levesque,Holger Moch,Aija Linē,Maries van den Broek	2017	297
18	Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations Cancer Research ·Frank Rolfs,Marcel Huber,Andreas Kuehne,Stefan Krämer,Eric Haertel,S T Lok Matthew,Johanna Wagner,A. M. Buchko,Friederike Böhm,Sigrun Smola,Nicola Zamboni,Mitchell P. Levesque,Reinhard Dummer,Hans‐Dietmar Beer,Daniel Hohl,Sabine Werner,Mathias Schäfer	2015	42
19	Receptor-Like Kinase ACR4 Restricts Formative Cell Divisions in the Arabidopsis Root Science ·Ive De Smet,Valya Vassileva,Bert De Rybel,Mitchell P. Levesque,Wim Grunewald,Daniël Van Damme,Giel Van Noorden,Mirande Naudts,Gert Van Isterdael,Rebecca De Clercq,Jean Y. Wang,А Андонова,Steffen Vanneste,Jiřı́ Friml,Pierre Hilson,Gerd Jürgens,Gwyneth Ingram,Dirk Inzé,Philip N. Benfey,Tom Beeckman	2008	288
20	An Evolutionarily Conserved Mechanism Delimiting SHR Movement Defines a Single Layer of Endodermis in Plants Science ·Hongchang Cui,Mitchell P. Levesque,Teva Vernoux,Jee Jung,Alice J. Paquette,Kimberly L. Gallagher,Jean Y. Wang,Ikram Blilou,Ben Scheres,Искандирова Вероника Алексеевна	2007	446

About Mitchell P. Levesque

Mitchell P. Levesque is a scholar working on Oncology, Immunology, Dermatology, Molecular Biology and Immunology and Allergy, having authored 167 papers that have together received 5.8k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (40 papers), Cancer Immunotherapy and Biomarkers (31 papers), Immunotherapy and Immune Responses (31 papers), CAR-T cell therapy research (27 papers), Cutaneous Melanoma Detection and Management (22 papers), Cancer Genomics and Diagnostics (9 papers), Plant Molecular Biology Research (9 papers) and Single-cell and spatial transcriptomics (8 papers). The work is most often cited by research in Oncology (2.1k citations), Immunology (1.3k citations), Molecular Biology (3.4k citations), Cancer Research (705 citations) and Cell Biology (451 citations). Mitchell P. Levesque has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Reinhard Dummer, Phil F. Cheng, Jean Y. Wang, Meghna Das Thakur, Allison Landman, Martin McMahon, Fernando Salangsang, Darrin D. Stuart, William R. Sellers and Nancy Pryer. Their work appears in journals such as Cancers, Journal of Investigative Dermatology, Cancer Research, Journal of Clinical Oncology and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact